Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Allison

Showing results (161-170 of 206) with videos related to

Pageof 21
Sort By:
JCI Insight|August 16, 2020
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunityKathleen M McAndrews, Dara P Dowlatshahi, Jianli Dai, et al.
Blood|March 28, 2015
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethalityRachelle G Veenstra, Ryan Flynn, Katharina Kreymborg, et al.
Cancer Cell|May 27, 2014
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survivalBerna C Özdemir, Tsvetelina Pentcheva-Hoang, Julienne L Carstens, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2019
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancerJorge Blando, Anu Sharma, Maria Gisela Higa, et al.
JCI Insight|October 4, 2019
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethalityAsim Saha, Patricia A Taylor, Christopher J Lees, et al.
Cancer Immunology Research|September 3, 2016
Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after ImmunotherapyDavid B Page, Jianda Yuan, David Redmond, et al.
Nature Communications|November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinomaMatthew T Campbell, Surena F Matin, Alda L Tam, et al.
Science Translational Medicine|April 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapyPavlos Msaouel, Sangeeta Goswami, Peter F Thall, et al.
Nature Communications|August 31, 2016
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activityChia-Wei Li, Seung-Oe Lim, Weiya Xia, et al.
Nature Communications|September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesRina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.
Pageof 21

Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
JCI Insight|August 16, 2020
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunityKathleen M McAndrews, Dara P Dowlatshahi, Jianli Dai, et al.
Blood|March 28, 2015
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethalityRachelle G Veenstra, Ryan Flynn, Katharina Kreymborg, et al.
Cancer Cell|May 27, 2014
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survivalBerna C Özdemir, Tsvetelina Pentcheva-Hoang, Julienne L Carstens, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2019
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancerJorge Blando, Anu Sharma, Maria Gisela Higa, et al.
JCI Insight|October 4, 2019
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethalityAsim Saha, Patricia A Taylor, Christopher J Lees, et al.
Cancer Immunology Research|September 3, 2016
Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after ImmunotherapyDavid B Page, Jianda Yuan, David Redmond, et al.
Nature Communications|November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinomaMatthew T Campbell, Surena F Matin, Alda L Tam, et al.
Science Translational Medicine|April 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapyPavlos Msaouel, Sangeeta Goswami, Peter F Thall, et al.
Nature Communications|August 31, 2016
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activityChia-Wei Li, Seung-Oe Lim, Weiya Xia, et al.
Nature Communications|September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesRina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.
Pageof 21